Insider trade

CEO sold ~$39K of CLOV shares in the open market

Traded Oct 5, 2026 · Filed Oct 6, 2026

~$39K
Approx. value · 8,750 sh @ $4.42: 2.79M
Holds after · shares reported: −1.7%
Since filing · from the first close after the filing, $4.68 → $4.60 on Oct 6, S&P 500 +0.6%

Why it stands out

The CEO of Clover Health Investments, Corp. /De sold $39K of Clover Health Investments, Corp. /De shares. The filing references tax withholding.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$38,675

Shares × reported transaction price

Timing vs results

61 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the "RSUs") on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.